In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models

JACC: Cardiovascular Imaging

Volumn 9, Issue 8, 2016, Pages 950-961

  Pérez Medina, Carlos ^a   Binderup, Tina ^b   Lobatto, Mark E ^a,c   Tang, Jun ^d   Calcagno, Claudia ^a   Giesen, Luuk ^a   Wessel, Chang Ho ^a   Witjes, Julia ^a   Ishino, Seigo ^a   Baxter, Samantha ^a   Zhao, Yiming ^a   Ramachandran, Sarayu ^a   Eldib, Mootaz ^a   Sánchez Gaytán, Brenda L ^a   Robson, Philip M ^a   Bini, Jason ^e   Granada, Juan F ^f   Fish, Kenneth M ^a   Stroes, Erik S G ^c   Duivenvoorden, Raphaël ^c   Tsimikas, Sotirios ^g   Lewis, Jason S ^d   Reiner, Thomas ^d   Fuster, Valentín ^a   Kjær, Andreas ^b   Fisher, Edward A ^h   Fayad, Zahi A ^a   Mulder, Willem J M ^a,c   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Yale University   (United States)

^f CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^h NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; high density lipoprotein; PET CT; PET MRI; zirconium 89

Indexed keywords

HIGH DENSITY LIPOPROTEIN; NANOPARTICLE; ZIRCONIUM 89; APOLIPOPROTEIN E; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; ZIRCONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTORADIOGRAPHY; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; EX VIVO STUDY; HEART SCINTISCANNING; IN VIVO STUDY; ISOTOPE LABELING; LIPID ANALYSIS; NONHUMAN; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PORCINE MODEL; POSITRON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RABBIT MODEL; RADIOACTIVITY; RETENTION TIME; TARGET ORGAN; WILD TYPE; ANIMAL; AORTA; AORTIC DISEASE; C57BL MOUSE; DEFICIENCY; DIAGNOSTIC IMAGING; DISEASE MODEL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IMAGING; GENETICS; KNOCKOUT MOUSE; LEPORIDAE; MALE; METABOLISM; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; TISSUE DISTRIBUTION; VALIDATION STUDY;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; AUTORADIOGRAPHY; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; LIPOPROTEINS, HDL; MAGNETIC RESONANCE IMAGING; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR IMAGING; OPTICAL IMAGING; PLAQUE, ATHEROSCLEROTIC; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RABBITS; RADIOISOTOPES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TISSUE DISTRIBUTION; ZIRCONIUM;

EID: 84969802426     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2016.01.020     Document Type: Article

References (33)

1. 1 Lusis, A.J., Atherosclerosis. Nature 407 (2000), 233–241.
2. 2 Libby, P., Inflammation in atherosclerosis. Nature 420 (2002), 868–874.
3. 3 Libby, P., Ridker, P.M., Hansson, G.K., Progress and challenges in translating the biology of atherosclerosis. Nature 473 (2011), 317–325.
4. 4 Fuster, V., Moreno, P.R., Fayad, Z.A., Corti, R., Badimon, J.J., Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 46 (2005), 937–954.
5. 5 Favari, E., Chroni, A., Tietge, U.J., Zanotti, I., Escolà-Gil, J.C., Bernini, F., Cholesterol efflux and reverse cholesterol transport. Handb Exp Pharmacol 224 (2015), 181–206.
6. 6 Badimon, J.J., Badimon, L., Fuster, V., Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest 85 (1990), 1234–1241.
7. 7 Rubin, E.M., Krauss, R.M., Spangler, E.A., Verstuyft, J.G., Clift, S.M., Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353 (1991), 265–267.
8. 8 Tardif, J.C., Grégoire, J., L'Allier, P.L., et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297 (2007), 1675–1682.
9. 9 Rader, D.J., Daugherty, A., Translating molecular discoveries into new therapies for atherosclerosis. Nature 451 (2008), 904–913.
10. 10 Van Eck, M., Pennings, M., Hoekstra, M., Out, R., Van Berkel, T.J., Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 16 (2005), 307–315.
11. 11 Yvan-Charvet, L., Wang, N., Tall, A.R., Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol 30 (2010), 139–143.
12. 12 Frias, J.C., Williams, K.J., Fisher, E., Fayad, Z., Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 126 (2004), 16316–16317.
13. 13 Cormode, D.P., Chandrasekar, R., Delshad, A., et al. Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis. Bioconjug Chem 20 (2009), 937–943.
14. 14 Bulte, J.W., Hot spot MRI emerges from the background. Nat Biotechnol 23 (2005), 945–946.
15. 15 Pérez-Medina, C., Abdel-Atti, D., Zhang, Y., et al. A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting. J Nucl Med 55 (2014), 1706–1712.
16. 16 Pérez-Medina, C., Tang, J., Abdel-Atti, D., et al. PET imaging of tumor-associated macrophages with 89Zr-labeled HDL nanoparticles. J Nucl Med 56 (2015), 1272–1277.
17. 17 Duivenvoorden, R., Tang, J., Cormode, D.P., et al. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat Commun, 5, 2014, 3065.
18. 18 Tang, J., Lobatto, M.E., Hassing, L., et al. Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Sci Adv, 1, 2015 e1400223.
19. 19 Westerterp, M., Bochem, A.E., Yvan-Charvet, L., Murphy, A.J., Wang, N., Tall, A.R., ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ Res 114 (2014), 157–170.
20. 20 Röhrl, C., Stangl, H., HDL endocytosis and resecretion. Biochim Biophys Acta 1831 (2013), 1626–1633.
21. 21 Braschi, S., Neville, T.A., Maugeais, C., Ramsamy, T.A., Seymour, R., Sparks, D.L., Role of the kidney in regulating the metabolism of HDL in rabbits: evidence that iodination alters the catabolism of apolipoprotein A-I by the kidney. Biochemistry 39 (2000), 5441–5449.
22. 22 Shaish, A., Keren, G., Chouraqui, P., Levkovitz, H., Harats, D., Imaging of aortic atherosclerotic lesions by 125I-LDL, 125I-oxidized-LDL, 125I-HDL and 125I-BSA. Pathobiology 69 (2001), 225–229.
23. 23 Zalutsky, M.R., Narula, A.S., A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine. Int J Radiat Appl Instrumentation Part A Appl Radiat Isot 38 (1987), 1051–1055.
24. 24 Glass, C.K., Pittman, R.C., Keller, G.A., Steinberg, D., Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem 258 (1983), 7161–7167.
25. 25 Moestrup, S.K., Nielsen, L.B., The role of the kidney in lipid metabolism. Curr Opin Lipidol 16 (2005), 301–306.
26. 26 Breznan, D., Veereswaran, V., Viau, F.J., Neville, T.A., Sparks, D.L., The lipid composition of high-density lipoprotein affects its re-absorption in the kidney by proximal tubule epithelial cells. Biochem J 379 (2004), 343–349.
27. 27 Krikken, J.A., Gansevoort, R.T., Dullaart, R.P., Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. J Lipid Res 51 (2010), 1982–1990.
28. 28 Eriksen, B.O., Løchen, M.L., Arntzen, K.A., et al. Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population. Kidney Int 86 (2014), 146–153.
29. 29 Hirakawa, H., Coprophagy in leporids and other mammalian herbivores. Mamm Rev 31 (2001), 61–80.
30. 30 Yvan-Charvet, L., Pagler, T., Gautier, E.L., et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 328 (2010), 1689–1693.
31. 31 Hewing, B., Parathath, S., Barrett, T., et al. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 34 (2014), 779–789.
32. 32 Sauter, A.W., Wehrl, H.F., Kolb, A., Judenhofer, M.S., Pichler, B.J., Combined PET/MRI: one step further in multimodality imaging. Trends Mol Med 16 (2010), 508–515.
33. 33 Rye, K.A., Barter, P.J., Regulation of high-density lipoprotein metabolism. Circ Res 114 (2014), 143–156.